Medscape |
BRAVO 3 TAVR and AF: Stroke Risk, Discharge Meds Differ
Medscape In the BRAVO-3 trial of patients who had transfemoral TAVR with procedural bivalirudin or heparin, patients with new-onset AF had a much greater stroke risk; … |
14
MAY
MAY
0